{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T15:30:23Z","timestamp":1795015823154,"version":"4.10.1"},"reference-count":43,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,7,20]]},"abstract":"<jats:title>Key Points<\/jats:title><jats:p>Genomic disruption of CD7 prior to CAR transduction allows generation of CD7 CAR T cells without extensive self-antigen-driven fratricide. CD7 CAR T cells have robust activity against T-cell malignancies in vitro and in vivo.<\/jats:p>","DOI":"10.1182\/blood-2017-01-761320","type":"journal-article","created":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T00:55:22Z","timestamp":1495673722000},"page":"285-296","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":449,"title":["CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies"],"prefix":"10.1182","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9615-3735","authenticated-orcid":false,"given":"Diogo","family":"Gomes-Silva","sequence":"first","affiliation":[{"name":"Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX;"},{"name":"Texas Children's Hospital, Houston, TX;"},{"name":"Houston Methodist Hospital, Houston, TX;"},{"name":"Department of Bioengineering and Institute for Bioengineering and Biosciences, Instituto Superior T\u00e9cnico, Universidade de Lisboa, Lisboa, Portugal;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhuwanti","family":"Srinivasan","sequence":"additional","affiliation":[{"name":"Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX;"},{"name":"Texas Children's Hospital, Houston, TX;"},{"name":"Houston Methodist Hospital, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhya","family":"Sharma","sequence":"additional","affiliation":[{"name":"Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX;"},{"name":"Texas Children's Hospital, Houston, TX;"},{"name":"Houston Methodist Hospital, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciaran M.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Bioengineering, Rice University, Houston, TX; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios L.","family":"Wagner","sequence":"additional","affiliation":[{"name":"Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX;"},{"name":"Texas Children's Hospital, Houston, TX;"},{"name":"Houston Methodist Hospital, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy H.","family":"Davis","sequence":"additional","affiliation":[{"name":"Department of Bioengineering, Rice University, Houston, TX; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayne H.","family":"Rouce","sequence":"additional","affiliation":[{"name":"Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX;"},{"name":"Texas Children's Hospital, Houston, TX;"},{"name":"Houston Methodist Hospital, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Bao","sequence":"additional","affiliation":[{"name":"Department of Bioengineering, Rice University, Houston, TX; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm K.","family":"Brenner","sequence":"additional","affiliation":[{"name":"Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX;"},{"name":"Texas Children's Hospital, Houston, TX;"},{"name":"Houston Methodist Hospital, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7178-8163","authenticated-orcid":false,"given":"Maksim","family":"Mamonkin","sequence":"additional","affiliation":[{"name":"Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX;"},{"name":"Texas Children's Hospital, Houston, TX;"},{"name":"Houston Methodist Hospital, Houston, TX;"},{"name":"Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"16","key":"2019111904521205800_B1","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N Engl J Med"},{"issue":"177","key":"2019111904521205800_B2","doi-asserted-by":"crossref","first-page":"177ra38","DOI":"10.1126\/scitranslmed.3005930","article-title":"CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia","volume":"5","author":"Brentjens","year":"2013","journal-title":"Sci Transl Med"},{"issue":"6","key":"2019111904521205800_B3","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1172\/JCI85309","article-title":"CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients","volume":"126","author":"Turtle","year":"2016","journal-title":"J Clin Invest"},{"issue":"8","key":"2019111904521205800_B4","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1182\/blood-2015-02-629527","article-title":"A T-cell-directed chimeric antigen receptor for the selective treatment of T-cell malignancies","volume":"126","author":"Mamonkin","year":"2015","journal-title":"Blood"},{"issue":"1","key":"2019111904521205800_B5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4049\/jimmunol.133.1.137","article-title":"Specific inhibition of in vitro lymphocyte transformation by an anti-pan T cell (gp67) ricin A chain immunotoxin","volume":"133","author":"Kernan","year":"1984","journal-title":"J Immunol"},{"issue":"12","key":"2019111904521205800_B6","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1158\/2159-8290.CD-15-1020","article-title":"Convergence of acquired mutations and alternative splicing of CD19 enables resistance to CART-19 immunotherapy","volume":"5","author":"Sotillo","year":"2015","journal-title":"Cancer Discov"},{"issue":"8","key":"2019111904521205800_B7","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nm.3910","article-title":"NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma","volume":"21","author":"Rapoport","year":"2015","journal-title":"Nat Med"},{"issue":"11","key":"2019111904521205800_B8","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1073\/pnas.76.11.5829","article-title":"Human lymphocyte antigens: production of a monoclonal antibody that defines functional thymus-derived lymphocyte subsets","volume":"76","author":"Haynes","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2019111904521205800_B9","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4049\/jimmunol.152.2.517","article-title":"Expression and function of CD7 molecule on human natural killer cells","volume":"152","author":"Rabinowich","year":"1994","journal-title":"J Immunol"},{"issue":"7","key":"2019111904521205800_B10","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1182\/blood.V77.7.1546.1546","article-title":"Stages of T-cell receptor protein expression in T-cell acute lymphoblastic leukemia","volume":"77","author":"Campana","year":"1991","journal-title":"Blood"},{"key":"2019111904521205800_B11","article-title":"Atlas of Differential Diagnosis in Neoplastic Hematopathology","author":"Gorczyca","year":"2014","edition":"3rd ed"},{"issue":"2","key":"2019111904521205800_B12","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/eji.1830250229","article-title":"Antibody ligation of CD7 leads to association with phosphoinositide 3-kinase and phosphatidylinositol 3,4,5-trisphosphate formation in T lymphocytes","volume":"25","author":"Ward","year":"1995","journal-title":"Eur J Immunol"},{"issue":"2","key":"2019111904521205800_B13","doi-asserted-by":"crossref","first-page":"934","DOI":"10.4049\/jimmunol.159.2.934","article-title":"CD7-mediated regulation of integrin adhesiveness on human T cells involves tyrosine phosphorylation-dependent activation of phosphatidylinositol 3-kinase","volume":"159","author":"Chan","year":"1997","journal-title":"J Immunol"},{"issue":"5","key":"2019111904521205800_B14","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1074\/jbc.275.5.3431","article-title":"Identification of CD7 as a cognate of the human K12 (SECTM1) protein","volume":"275","author":"Lyman","year":"2000","journal-title":"J Biol Chem"},{"issue":"12","key":"2019111904521205800_B15","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1093\/intimm\/9.12.1875","article-title":"Targeted gene disruption of murine CD7","volume":"9","author":"Bonilla","year":"1997","journal-title":"Int Immunol"},{"issue":"12","key":"2019111904521205800_B16","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.4049\/jimmunol.160.12.5749","article-title":"Immunologic characterization of CD7-deficient mice","volume":"160","author":"Lee","year":"1998","journal-title":"J Immunol"},{"issue":"3","key":"2019111904521205800_B17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2141.1988.tb02484.x","article-title":"Relationship between internalization and cytotoxicity of ricin A-chain immunotoxins","volume":"70","author":"Preijers","year":"1988","journal-title":"Br J Haematol"},{"issue":"3-4","key":"2019111904521205800_B18","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/10428199709051778","article-title":"Therapy of patients with T-cell lymphomas and leukemias using an anti-CD7 monoclonal antibody-ricin A chain immunotoxin","volume":"26","author":"Frankel","year":"1997","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"2019111904521205800_B19","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.4049\/jimmunol.158.7.3259","article-title":"Construction and characterization of human CD7-specific single-chain Fv immunotoxins","volume":"158","author":"Pauza","year":"1997","journal-title":"J Immunol"},{"issue":"2","key":"2019111904521205800_B20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1046\/j.1365-2141.1996.d01-1900.x","article-title":"Therapy with CD7 monoclonal antibody TH-69 is highly effective for xenografted human T-cell ALL","volume":"95","author":"Baum","year":"1996","journal-title":"Br J Haematol"},{"issue":"12","key":"2019111904521205800_B21","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1038\/mtna.2014.64","article-title":"COSMID: a Web-based tool for identifying and validating CRISPR\/Cas off-target sites","volume":"3","author":"Cradick","year":"2014","journal-title":"Mol Ther Nucleic Acids"},{"issue":"10","key":"2019111904521205800_B22","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/nmeth.3543","article-title":"CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo","volume":"12","author":"Moreno-Mateos","year":"2015","journal-title":"Nat Methods"},{"issue":"5","key":"2019111904521205800_B23","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.celrep.2016.09.092","article-title":"Highly efficient genome editing of murine and human hematopoietic progenitor cells by CRISPR\/Cas9","volume":"17","author":"Gundry","year":"2016","journal-title":"Cell Reports"},{"key":"2019111904521205800_B24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-6472-7_1","article-title":"Design and validation of CRISPR\/Cas9 systems for targeted gene modification in induced pluripotent stem cells","volume":"1498","author":"Lee","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"6121","key":"2019111904521205800_B25","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"issue":"2","key":"2019111904521205800_B26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nbt.3117","article-title":"GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases","volume":"33","author":"Tsai","year":"2015","journal-title":"Nat Biotechnol"},{"issue":"3","key":"2019111904521205800_B27","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/mt.2016.8","article-title":"The Neisseria meningitidis CRISPR-Cas9 system enables specific genome editing in mammalian cells","volume":"24","author":"Lee","year":"2016","journal-title":"Mol Ther"},{"issue":"11","key":"2019111904521205800_B28","doi-asserted-by":"crossref","first-page":"7473","DOI":"10.1093\/nar\/gku402","article-title":"CRISPR\/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences","volume":"42","author":"Lin","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"18 Pt 1","key":"2019111904521205800_B29","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1158\/1078-0432.CCR-07-0674","article-title":"Genetically targeted T cells eradicate systemic acute lymphoblastic leukemia xenografts","volume":"13","author":"Brentjens","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"10","key":"2019111904521205800_B30","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJMoa1300662","article-title":"Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV","volume":"370","author":"Tebas","year":"2014","journal-title":"N Engl J Med"},{"issue":"23","key":"2019111904521205800_B31","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1182\/blood.V126.23.2046.2046","article-title":"First clinical application of Talen engineered universal CAR19 T cells in B-ALL","volume":"126","author":"Qasim","year":"2015","journal-title":"Blood"},{"issue":"2","key":"2019111904521205800_B32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nm.3793","article-title":"Therapeutic genome editing: prospects and challenges","volume":"21","author":"Cox","year":"2015","journal-title":"Nat Med"},{"issue":"5","key":"2019111904521205800_B33","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1073\/pnas.0507496103","article-title":"Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells","volume":"103","author":"Recchia","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2019111904521205800_B34","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJM200301163480314","article-title":"A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency","volume":"348","author":"Hacein-Bey-Abina","year":"2003","journal-title":"N Engl J Med"},{"issue":"8","key":"2019111904521205800_B35","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/intimm\/8.8.1195","article-title":"Functional association of CD7 with phosphatidylinositol 3-kinase: interaction via a YEDM motif","volume":"8","author":"Lee","year":"1996","journal-title":"Int Immunol"},{"issue":"1","key":"2019111904521205800_B36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10875-005-0356-5","article-title":"Expression of the CD7 ligand K-12 in human thymic epithelial cells: regulation by IFN-gamma","volume":"25","author":"Lam","year":"2005","journal-title":"J Clin Immunol"},{"issue":"3","key":"2019111904521205800_B37","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1006\/geno.1997.5151","article-title":"Identification and characterization of K12 (SECTM1), a novel human gene that encodes a Golgi-associated protein with transmembrane and secreted isoforms","volume":"47","author":"Slentz-Kesler","year":"1998","journal-title":"Genomics"},{"issue":"3","key":"2019111904521205800_B38","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1189\/jlb.1011498","article-title":"K12\/SECTM1, an interferon-\u03b3 regulated molecule, synergizes with CD28 to costimulate human T cell proliferation","volume":"91","author":"Wang","year":"2012","journal-title":"J Leukoc Biol"},{"issue":"5","key":"2019111904521205800_B39","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.4049\/jimmunol.165.5.2331","article-title":"CD7 delivers a pro-apoptotic signal during galectin-1-induced T cell death","volume":"165","author":"Pace","year":"2000","journal-title":"J Immunol"},{"issue":"5","key":"2019111904521205800_B40","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.4049\/jimmunol.150.5.2081","article-title":"CD7- T cells represent a subset of normal human blood lymphocytes","volume":"150","author":"Reinhold","year":"1993","journal-title":"J Immunol"},{"issue":"3","key":"2019111904521205800_B41","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1365-2567.1996.d01-744.x","article-title":"CD7-negative T cells represent a separate differentiation pathway in a subset of post-thymic helper T cells","volume":"89","author":"Reinhold","year":"1996","journal-title":"Immunology"},{"issue":"242","key":"2019111904521205800_B42","doi-asserted-by":"crossref","first-page":"242ra83","DOI":"10.1126\/scitranslmed.3008825","article-title":"Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT","volume":"6","author":"Papadopoulou","year":"2014","journal-title":"Sci Transl Med"},{"issue":"18","key":"2019111904521205800_B43","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJMoa1106152","article-title":"Inducible apoptosis as a safety switch for adoptive cell therapy","volume":"365","author":"Di Stasi","year":"2011","journal-title":"N Engl J Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/130\/3\/285\/1404621\/blood761320.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/130\/3\/285\/1404621\/blood761320.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T18:39:51Z","timestamp":1692815991000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/130\/3\/285\/36917\/CD7edited-T-cells-expressing-a-CD7specific-CAR-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,20]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,7,20]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2017-01-761320","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,20]]}}}